Cambodia Compass report, 26th May - Bharat Biotech International, a vaccine innovator, has applied for approval in more than 60 countries, including the United States, Brazil, and Hungary, for its indigenously produced Covid-19 vaccine Covaxin.
The vaccine maker said in a statement on Tuesday evening that it had received emergency use authorizations from 13 countries so far, with more on the way.
Mexico, the Philippines, Iran, Paraguay, Guatemala, Nicaragua, Guyana, Venezuela, Botswana, and Zimbabwe are among the countries that have issued emergency use licenses (EUL).
Bharat Biotech has also submitted an EUL application to the World Health Organization (WHO), with regulatory approvals expected in the July-September quarter.
Bharat Biotech's head of business growth and international advocacy, Raches Ella, told a conference of women entrepreneurs in Hyderabad on Saturday that the vaccine maker was pursuing pre-qualification approvals from the WHO for Covaxin. “In the past, they (WHO) approved a few of our products. Covaxin is expected to be approved by the end of Q3 or Q4.”
Source: Cambodia Compass comprehensive arrangement
Editor: Malinda Chief Editor: Sunnie General in Chief/Executive Producer: Nicole
Compass global site: Cambodia | Singapore | UAE | Thailand | Philippines | Myanmar | Laos
Disclaimer: The re-forward articles on Compass website are for the purpose of conveying more information, and it does not mean that the Compass website agrees with its views or confirms the authenticity of its content. Article noted as "Source: Compass original", please note that the source from Compass. The content of the article is for reference only and should not consider as investment advice, and it does not mean that Compass agree with its views.
0
+855 (0) 23222206 (CN/EN/KH)
+86 023 67480241 (CN)
+855 (0) 66400666 (CN/EN/KH)
cpassre@gmail.com
https://www.compass.com.kh
Office Building Ground floor, Kbal Dey No. 594, Street Wat Chas, Phum 01, Sangkat Chroy Changva, Khan Chroy Changva, Phnom Penh
Cambodia
